Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment

被引:259
作者
Maffei, L
Murata, Y
Rochira, V
Tubert, G
Aranda, C
Vazquez, M
Clyne, CD
Davis, S
Simpson, ER
Carani, C
机构
[1] Univ Modena & Reggio Emilia, Dept Internal Med, Chair Endocrinol, I-41100 Modena, Italy
[2] Consultorios Asociados Endocrinol, RA-1425 Buenos Aires, DF, Argentina
[3] Tomog Computada Buenos Aires, RA-1425 Buenos Aires, DF, Argentina
[4] Jean Hailes Fdn, Clayton, Vic, Australia
[5] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
关键词
D O I
10.1210/jc.2003-030313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present the fourth case of an adult man (29 yr old) affected by aromatase deficiency resulting from a novel homozygous inactivating mutation of the CYP19 ( P450(arom)) gene. At first observation, continuing linear growth, eunuchoid body proportions, diffuse bone pain, and bilateral cryptorchidism were observed. The patient presented also a complex dysmetabolic syndrome characterized by insulin resistance, diabetes mellitus type 2, acanthosis nigricans, liver steatohepatitis, and signs of precocious atherogenesis. The analysis of the effects induced by the successive treatment with high doses of testosterone, alendronate, and estradiol allows further insight into the roles of androgens and estrogens on several metabolic functions. High doses of testosterone treatment resulted in a severe imbalance in the estradiol to testosterone ratio together with the occurrence of insulin resistance and diabetes mellitus type 2. Estrogen treatment resulted in an improvement of acanthosis nigricans, insulin resistance, and liver steatohepatitis, coupled with a better glycemic control and the disappearance of two carotid plaques. Furthermore, the study confirms previous data concerning the key role of estrogens on male bone maturation, at least in part, and regulation of gonadotropin secretion. The biopsy of the testis showed a pattern of total germ cell depletion that might be due to the concomitant presence of bilateral cryptorchidism. Thus, a possible role of estrogen in male reproductive function is suggested but without revealing a direct cause-effect relationship. Data from this case provide new insights into the role of estrogens in glucose, lipid, and liver metabolism in men. This new case of aromatase deficiency confirms previous data on bone maturation and mineralization, and it reveals a high risk for the precocious development of cardiovascular disease in young aromatase-deficient men.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 44 条
  • [1] AROMATIZATION OF ANDROSTENEDIONE BY HUMAN ADIPOSE-TISSUE STROMAL CELLS IN MONOLAYER-CULTURE
    ACKERMAN, GE
    SMITH, ME
    MENDELSON, CR
    MACDONALD, PC
    SIMPSON, ER
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (02) : 412 - 417
  • [2] Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the framingham study
    Amin, S
    Zhang, YQ
    Sawin, DT
    Evans, SR
    Hannan, MT
    Kiel, DP
    Wilson, PWF
    Felson, DT
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) : 951 - 963
  • [3] [Anonymous], 85 ANN M END SOC PHI
  • [4] SERUM TESTOSTERONE LEVEL IS THE MAJOR DETERMINANT OF THE MALE-FEMALE DIFFERENCES IN SERUM LEVELS OF HIGH-DENSITY-LIPOPROTEIN (HDL) CHOLESTEROL AND HDL(2) CHOLESTEROL
    ASSCHEMAN, H
    GOOREN, LJG
    MEGENS, JAJ
    NAUTA, J
    KLOOSTERBOER, HJ
    EIKELBOOM, F
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (08): : 935 - 939
  • [5] Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
    Bilezikian, JP
    Morishima, A
    Bell, J
    Grumbach, MM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 599 - 603
  • [6] Effect of testosterone and estradiol in a man with aromatase deficiency
    Carani, C
    Qin, K
    Simoni, M
    FaustiniFustini, M
    Serpente, S
    Boyd, J
    Korach, KS
    Simpson, ER
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) : 91 - 95
  • [7] Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women
    Christian, RC
    Harrington, S
    Edwards, WD
    Oberg, AL
    Fitzpatrick, LA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1062 - 1067
  • [8] ISOLATION OF A FULL-LENGTH CDNA INSERT ENCODING HUMAN AROMATASE SYSTEM CYTOCHROME-P-450 AND ITS EXPRESSION IN NONSTEROIDOGENIC CELLS
    CORBIN, CJ
    GRAHAMLORENCE, S
    MCPHAUL, M
    MASON, JI
    MENDELSON, CR
    SIMPSON, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 8948 - 8952
  • [9] Estrogen receptor null mice: What have we learned and where will they lead us?
    Couse, JF
    Korach, KS
    [J]. ENDOCRINE REVIEWS, 1999, 20 (03) : 358 - 417
  • [10] Donaldson KM, 1996, J ANDROL, V17, P91